Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
211.50    1.00 (0.47%)
Bid:
210.00
Ask:
213.00
Spread: 3.00 (1.429%)
Market Cap: £145.34m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

21 Nov 2017 07:00

RNS Number : 0311X
Helios Underwriting Plc
21 November 2017
 

 

 

Helios Underwriting plc

("Helios" or the "Company")

Quarterly Syndicate Mid-point Forecasts

 

Helios announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2015 and 2016 years of account based on 3rd quarter 2017 results.

 

 

 

Year of Account

 

 

 

 

 

 

 

2015

2016

2017

 

 

£m

£m

£m

Capacity - Position at 1st Jan 2017

 

32.2

33.7

32.6

 

Retained

16.1

10.9

9.8

 

Reinsured

16.2

22.8

22.8

 

 

 

 

 

Capacity acquired since 1 January 2017

 

 

 

 

 

Retained

3.7

3.8

1.8

 

Quota Share

Commutation

-

3.3

-

 

Increase in Retained

3.7

7.1

1.8

 

Reinsured

0.4

(2.9)

2.6

 

 

 

 

 

Capacity - Position as at 20th November 2017

 

 

 

 

 

Retained

19.8

18.0

11.6

 

Reinsured

16.6

19.9

25.4

 

 

36.4

37.9

37.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mid-point forecast at 30th June 2017

 

10.82%

3.77%

 

Current mid-point forecast

 

10.99%

2.98%

N/A

 

 

 

 

 

Lloyd's Market Average 3rd Qtr

 

4.63%

(2.72)%

 

Helios outperformance

 

6.36%

5.70%

 

 

Notes

1) The tables show the movement in capacity as a result of acquisitions made since 1st Jan 2017 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers.

2) The mid point forecasts as of 3rd quarter 2017 have been aggregated at syndicate level from estimates supplied by managing agents.

3) The midpoint estimates for 2016 year of account have reduced during the quarter having been impacted by the 3rd quarter 2017 hurricane losses.

4) The impact on Helios will be as follows:

a. The additional capacity acquired on the open years will make a contribution to the earnings of Helios although part of the result will have been earned in prior years or will be treated as pre-acquisition profits. 

b. The increase in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement this year.

c. The overall improvement in the result will be received by Helios in cash when the profits are distributed after the close of the year of account.

 

 

For further information please contact:

Helios

Nigel Hanbury - Chief Executive 020 7863 6655 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

Stockdale

Robert Finlay 020 7601 6100

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £36.3m of capacity for the 2017 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGGWAGUPMGMU
Date   Source Headline
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings
2nd Oct 20237:00 amRNSTotal Voting Rights
28th Sep 20237:00 amRNSHalf Year Results
11th Sep 202311:46 amRNSTransaction in Own Shares
8th Sep 202310:23 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20233:27 pmRNSTransaction in Own Shares
4th Sep 20233:36 pmRNSTransaction in Own Shares
1st Sep 202311:06 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.